Literature DB >> 33634968

Clinical significance and immune landscapes of stemness-related and immune gene set-based signature in oral cancer.

Xian Lin1,2, Xiongzhou Zheng3, Baihua Yang4, Jian Chen1,2, Qin Xu4, Qingwen Wang1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33634968      PMCID： PMC7893806          DOI： 10.1002/ctm2.343

Source DB:  PubMed          Journal:  Clin Transl Med        ISSN： 2001-1326


× No keyword cloud information.
  10 in total

1.  Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.

Authors:  Tathiane M Malta; Artem Sokolov; Andrew J Gentles; Tomasz Burzykowski; Laila Poisson; John N Weinstein; Bożena Kamińska; Joerg Huelsken; Larsson Omberg; Olivier Gevaert; Antonio Colaprico; Patrycja Czerwińska; Sylwia Mazurek; Lopa Mishra; Holger Heyn; Alex Krasnitz; Andrew K Godwin; Alexander J Lazar; Joshua M Stuart; Katherine A Hoadley; Peter W Laird; Houtan Noushmehr; Maciej Wiznerowicz
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

2.  Survival outcomes after treatment of cancer of the oral cavity (1985-2015).

Authors:  Daniella Karassawa Zanoni; Pablo H Montero; Jocelyn C Migliacci; Jatin P Shah; Richard J Wong; Ian Ganly; Snehal G Patel
Journal:  Oral Oncol       Date:  2019-02-15       Impact factor: 5.337

3.  Trajectories of returning to work and its impact on survival in survivors with oral cancer: A 5-year follow-up study.

Authors:  Yuan-Yuei Chen; Chung-Ching Wang; Wei-Te Wu; Ching-Huang Lai; Ching-Liang Ho; Ya-Yuan Hsu; Wei-Liang Chen
Journal:  Cancer       Date:  2019-12-06       Impact factor: 6.860

4.  Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.

Authors:  Sabina Signoretti; Catherine J Wu; Sachet A Shukla; Toni K Choueiri; David A Braun; Yue Hou; Ziad Bakouny; Miriam Ficial; Miriam Sant' Angelo; Juliet Forman; Petra Ross-Macdonald; Ashton C Berger; Opeyemi A Jegede; Liudmilla Elagina; John Steinharter; Maxine Sun; Megan Wind-Rotolo; Jean-Christophe Pignon; Andrew D Cherniack; Lee Lichtenstein; Donna Neuberg; Paul Catalano; Gordon J Freeman; Arlene H Sharpe; David F McDermott; Eliezer M Van Allen
Journal:  Nat Med       Date:  2020-05-29       Impact factor: 53.440

5.  Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer.

Authors:  Anthony D Saleh; Hui Cheng; Scott E Martin; Han Si; Pinar Ormanoglu; Sophie Carlson; Paul E Clavijo; Xinping Yang; Rita Das; Shaleeka Cornelius; Jamie Couper; Douglas Chepeha; Ludmila Danilova; Thomas M Harris; Michael B Prystowsky; Geoffrey J Childs; Richard V Smith; A Gordon Robertson; Steven J M Jones; Andrew D Cherniack; Sang S Kim; Antonina Rait; Kathleen F Pirollo; Esther H Chang; Zhong Chen; Carter Van Waes
Journal:  Clin Cancer Res       Date:  2019-02-05       Impact factor: 12.531

6.  Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma.

Authors:  Chaoqi Zhang; Zhen Zhang; Guochao Zhang; Zhihui Zhang; Yuejun Luo; Feng Wang; Sihui Wang; Yun Che; Qingpeng Zeng; Nan Sun; Jie He
Journal:  Cancer Lett       Date:  2020-03-19       Impact factor: 8.679

7.  Adjuvant radiation for T1-2N1 oral cavity cancer survival outcomes and utilization treatment trends: Analysis of the SEER database.

Authors:  Vanessa Torrecillas; Hailey M Shepherd; Sam Francis; Luke O Buchmann; Marcus M Monroe; Shane Lloyd; Donald Cannon; Ying J Hitchcock; John R Weis; Jason P Hunt; Jeffrey J Houlton; Richard B Cannon
Journal:  Oral Oncol       Date:  2018-08-06       Impact factor: 5.337

8.  The Immune Landscape of Cancer.

Authors:  Vésteinn Thorsson; David L Gibbs; Scott D Brown; Denise Wolf; Dante S Bortone; Tai-Hsien Ou Yang; Eduard Porta-Pardo; Galen F Gao; Christopher L Plaisier; James A Eddy; Elad Ziv; Aedin C Culhane; Evan O Paull; I K Ashok Sivakumar; Andrew J Gentles; Raunaq Malhotra; Farshad Farshidfar; Antonio Colaprico; Joel S Parker; Lisle E Mose; Nam Sy Vo; Jianfang Liu; Yuexin Liu; Janet Rader; Varsha Dhankani; Sheila M Reynolds; Reanne Bowlby; Andrea Califano; Andrew D Cherniack; Dimitris Anastassiou; Davide Bedognetti; Younes Mokrab; Aaron M Newman; Arvind Rao; Ken Chen; Alexander Krasnitz; Hai Hu; Tathiane M Malta; Houtan Noushmehr; Chandra Sekhar Pedamallu; Susan Bullman; Akinyemi I Ojesina; Andrew Lamb; Wanding Zhou; Hui Shen; Toni K Choueiri; John N Weinstein; Justin Guinney; Joel Saltz; Robert A Holt; Charles S Rabkin; Alexander J Lazar; Jonathan S Serody; Elizabeth G Demicco; Mary L Disis; Benjamin G Vincent; Ilya Shmulevich
Journal:  Immunity       Date:  2018-04-05       Impact factor: 43.474

9.  Inferring tumour purity and stromal and immune cell admixture from expression data.

Authors:  Kosuke Yoshihara; Maria Shahmoradgoli; Emmanuel Martínez; Rahulsimham Vegesna; Hoon Kim; Wandaliz Torres-Garcia; Victor Treviño; Hui Shen; Peter W Laird; Douglas A Levine; Scott L Carter; Gad Getz; Katherine Stemke-Hale; Gordon B Mills; Roel G W Verhaak
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.

Authors:  Hyunchul Jung; Hong Sook Kim; Jeong Yeon Kim; Jong-Mu Sun; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park; Manel Esteller; Se-Hoon Lee; Jung Kyoon Choi
Journal:  Nat Commun       Date:  2019-09-19       Impact factor: 14.919
  10 in total
  3 in total

1.  PYHIN1 correlates with CD8+ T cells infiltration and confers good patient survival in oral cancer.

Authors:  Jian-Ming Ding; Wen-Rong Lin; Zhao-Dong Fei; Chuan-Ben Chen
Journal:  J Dent Sci       Date:  2021-07-08       Impact factor: 2.080

2.  N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance.

Authors:  Xian Lin; Feng Wang; Jian Chen; Jing Liu; Yi-Bin Lin; Li Li; Chuan-Ben Chen; Qin Xu
Journal:  Mil Med Res       Date:  2022-04-14

3.  Cancer stemness-associated LINC02475 serves as a novel biomarker for diagnosis and prognosis prediction of hepatocellular carcinoma.

Authors:  Xian Lin; Lianxiang Luo; Yujiao Zou; Jian Chen
Journal:  Front Genet       Date:  2022-09-02       Impact factor: 4.772
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.